Premium
Tocilizumab's efficacy in patients with Coronavirus Disease 2019 (COVID‐19) is determined by the presence of cytokine storm
Author(s) -
Andrianopoulos Ioannis,
Papathanasiou Athanasios,
Papathanakos Georgios,
Chaidos Aristeidis,
Koulouras Vasilios
Publication year - 2021
Publication title -
journal of medical virology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.782
H-Index - 121
eISSN - 1096-9071
pISSN - 0146-6615
DOI - 10.1002/jmv.26209
Subject(s) - cytokine storm , tocilizumab , covid-19 , virology , coronavirus , medicine , cytokine , disease , immunology , infectious disease (medical specialty) , outbreak
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom